🔍 Definition
Congenital malformations of the circulatory system are structural abnormalities of the heart and great vessels that arise during fetal development, present at birth, and are classified within ICD-10-CM categories Q20–Q28. The spectrum ranges from minor lesions (e.g., small muscular ventricular septal defects that close spontaneously) to life-threatening critical defects requiring immediate neonatal intervention. According to the CDC, congenital heart defects (CHD) are the most common type of birth defect, occurring in approximately 1 in 100 live births in the United States—roughly 40,000 births per year.
Congenital heart disease specifically refers to structural malformations of the cardiac chambers, septa, valves, and great vessels resulting from abnormal embryologic cardiovascular development. These include defects of the cardiac septa (Q20–Q21), valvular malformations (Q22–Q23), other cardiac anomalies (Q24), great artery defects (Q25), great vein anomalies (Q26), and peripheral vascular malformations (Q27–Q28), as defined by the American Heart Association.
Critical congenital heart disease (CCHD) refers to the subset of CHD requiring catheter or surgical intervention in the first year of life. The seven classic “CCHD” lesions include hypoplastic left heart syndrome (HLHS), pulmonary atresia, tetralogy of Fallot, total anomalous pulmonary venous return, transposition of the great arteries, tricuspid atresia, and truncus arteriosus.
Coding permanence: Per ICD-10-CM Official Coding Guidelines, Chapter 17, codes from Q00–QA1 may be used throughout the life of the patient if the condition is still clinically present. Once a defect has been fully corrected and is no longer clinically active, assign Z87.74 (Personal history of corrected congenital malformations of heart and circulatory system). If the condition has been addressed but not fully corrected—or if residual effects persist—the Q code remains appropriate.
🗂️ Alternative Terminology
Clinicians, surgeons, and cardiologists use a wide range of terms for congenital circulatory malformations. Coders must recognize these aliases to ensure accurate code assignment.
| Formal / ICD-10-CM Term | Common / Lay / Clinical Aliases |
|---|---|
| Ventricular septal defect (Q21.0) | VSD; “hole in the heart”; interventricular communication |
| Atrial septal defect (Q21.10–Q21.19) | ASD; secundum ASD; ostium primum ASD; sinus venosus defect; patent foramen ovale (Q21.12) |
| Atrioventricular septal defect (Q21.20–Q21.23) | AVSD; AV canal defect; endocardial cushion defect; AV septal defect |
| Tetralogy of Fallot (Q21.3) | TOF; Fallot’s tetralogy; “blue baby” (cyanotic); VSD + pulmonary stenosis + overriding aorta + RVH |
| Pulmonary valve atresia (Q22.0) | Pulmonary atresia; PA; congenital absence of pulmonary valve |
| Congenital pulmonary valve stenosis (Q22.1) | Pulmonic stenosis; PS; valvular pulmonary stenosis |
| Ebstein’s anomaly (Q22.5) | Ebstein malformation; tricuspid dysplasia/displacement |
| Hypoplastic right heart syndrome (Q22.6) | HRHS; underdeveloped right heart |
| Congenital stenosis of aortic valve (Q23.0) | Congenital aortic stenosis; AS; bicuspid aortic valve stenosis |
| Bicuspid aortic valve (Q23.81) | BAV; two-leaflet aortic valve |
| Hypoplastic left heart syndrome (Q23.4) | HLHS; underdeveloped left heart; Norwood syndrome |
| Common arterial trunk (Q20.0) | Truncus arteriosus; TA; persistent truncus |
| Discordant ventriculoarterial connection (Q20.3) | Transposition of the great arteries; TGA; D-TGA; complete transposition |
| Patent ductus arteriosus (Q25.0) | PDA; persistent ductus; open ductus |
| Coarctation of aorta (Q25.1) | CoA; aortic coarctation; narrowing of the aorta |
| Total anomalous pulmonary venous connection (Q26.2) | TAPVC; TAPVR; total anomalous pulmonary venous return |
| Congenital mitral stenosis (Q23.2) | Congenital MS; parachute mitral valve |
| Dextrocardia (Q24.0) | Right-sided heart; mirror-image dextrocardia |
🩺 Signs & Symptoms
Clinical presentation of congenital circulatory malformations varies markedly by defect type, severity, and whether the lesion is cyanotic or acyanotic. Coders and CDI specialists should recognize these presentations to validate documented diagnoses and identify potential secondary conditions (e.g., pulmonary hypertension, heart failure).
Cyanotic CHD (right-to-left shunting; reduced pulmonary blood flow): Central cyanosis (bluish discoloration of lips, tongue, fingernails), “tet spells” (hypercyanotic episodes in TOF), severe hypoxia on pulse oximetry, poor feeding, tachypnea, clubbing of digits (chronic), polycythemia. Conditions: TOF, TGA, tricuspid atresia, pulmonary atresia, HLHS, TAPVC.
Acyanotic CHD (left-to-right shunting; increased pulmonary blood flow): Pulmonary overcirculation signs—tachypnea, diaphoresis with feeding, poor weight gain, frequent respiratory infections, congestive heart failure (CHF). Systolic murmurs at left sternal border (VSD), fixed split S2 (ASD), continuous machinery murmur (PDA). Conditions: VSD, ASD, AVSD, PDA.
Obstructive lesions: Upper extremity hypertension with diminished or delayed femoral pulses (coarctation of aorta), systolic ejection murmur radiating to neck (aortic stenosis), right ventricular outflow tract gradient (pulmonary stenosis), syncope or exercise intolerance.
Secondary complications: Pulmonary arterial hypertension (I27.21) from chronic left-to-right shunting (Eisenmenger physiology → I27.83), infective endocarditis risk (especially unrepaired VSDs, bicuspid aortic valve), arrhythmias (post-repair TOF → ventricular tachycardia, complete heart block), paradoxical embolism via ASD/PFO, stroke (TIA), developmental delay, exercise intolerance.
When documentation notes “cyanosis,” “low O2 saturation,” or “blue spells” in a patient with known or suspected CHD, query the provider to clarify whether a specific congenital cardiac defect is present, whether it is repaired or unrepaired, and whether any associated conditions (pulmonary hypertension, heart failure, arrhythmia) are present and clinically relevant to the current encounter.
🧭 Differential Diagnosis
CHD must be distinguished from acquired cardiac conditions and other causes of similar presentations. The following differential diagnoses are relevant for coders and CDI specialists reviewing documentation.
| Condition | Key Distinguishing Features | Relevant ICD-10-CM Code |
|---|---|---|
| Congenital VSD (Q21.0) | Congenital structural defect; present at birth; typical L→R shunt; holosystolic murmur | Q21.0 |
| Acquired ventricular septal defect | Post-MI VSD; rupture of interventricular septum; not congenital | I23.2 |
| Congenital ASD (Q21.1x) | Present at birth; fixed split S2; may present in adulthood | Q21.10–Q21.19 |
| Patent foramen ovale (Q21.12) | Failure of fetal foramen to close; may remain asymptomatic; risk of paradoxical embolism | Q21.12 |
| Acquired aortic stenosis | Degenerative calcification; older adults; NOT congenital; different code | I35.0 |
| Congenital aortic stenosis (Q23.0) | Congenital valvular anomaly; younger patients; often bicuspid valve | Q23.0 |
| Pulmonary hypertension (primary) | No underlying structural CHD; idiopathic or heritable PAH | I27.0 |
| Secondary PAH from CHD shunting | Long-standing L→R shunt leading to pulmonary vascular remodeling | I27.21 + Q-code |
| Eisenmenger syndrome | Reversal of shunt to R→L due to pulmonary HTN; specific code | I27.83 |
| Marfan syndrome with aortic dilation | Connective tissue disorder; aortic root dilation; genetic etiology | Q87.410 |
| Rheumatic heart disease (mitral/aortic) | Acquired; post-streptococcal; valve deformity from inflammation | I05.x–I08.x |
| Trisomy 21 (Down syndrome) with CHD | Genetic syndrome; AVSD (Q21.2) common comorbidity | Q90.x + Q21.2x |
| Di George’s syndrome / 22q11.2 deletion (velocardiofacial syndrome) | Genetic/immunologic or chromosomal diagnosis; conotruncal defects, TOF, truncus arteriosus, and interrupted aortic arch may occur | D82.1 for Di George’s syndrome; Q93.81 for documented 22q11.2 deletion/velocardiofacial syndrome |
| Cardiomyopathy (congenital) | Myocardial dysfunction; not structural septal/valvular defect | Q24.8 or I42.x |
📋 Clinical Indicators
The following clinical indicators should prompt code assignment, CDI queries, or documentation clarification. Coders should ensure that all documented conditions meeting the definition of a reportable diagnosis are captured.
| Clinical Indicator | Action / Code Implication |
|---|---|
| Echocardiogram confirming specific defect (VSD, ASD, PDA, AVSD, TOF, etc.) | Assign most specific Q20–Q28 code; do not use unspecified codes if specificity is available |
| Cardiac catheterization report documenting anatomic lesion | Assign specific defect code; also code any concurrent procedures (CPT) |
| Surgeon’s operative report describing defect being repaired | Assign both the congenital defect code and appropriate CPT repair code |
| “History of” CHD repair — clarify active vs. resolved | Query provider: if still present/residual effects → Q-code; if fully corrected → Z87.74 |
| Documented pulmonary hypertension in setting of CHD | Code I27.21 (secondary PAH) + Q-code for underlying CHD as instructed by tabular “code also” note |
| Down syndrome (Q90.x), Di George’s syndrome (D82.1), or documented 22q11.2 deletion/velocardiofacial syndrome (Q93.81) with CHD | Code both the syndrome/genetic condition and the specific cardiac defect when documented |
| Norwood/Fontan palliation documentation | Assign appropriate CPT for palliation stage; code CHD and applicable Z95.x device/graft status; add I27.84- when Fontan-related circulation or a Fontan-associated condition is documented |
| Eisenmenger syndrome documented | Assign I27.83 + underlying structural defect Q-code |
| Bicuspid aortic valve (BAV) documented | Q23.81 when BAV is documented without congenital aortic valve stenosis or insufficiency as the sole finding; code documented stenosis or insufficiency separately as supported by the record |
| Atrial septal defect type specified (secundum, coronary sinus, sinus venosus, PFO, other specified) | Use specific Q21.11–Q21.19 subcodes when documented; do not default to Q21.10 (unspecified) |
| Heart failure (I50.x) documented with CHD | Code both; CHF may be a manifestation of the structural defect or separate condition |
| Arrhythmia documented post-CHD repair | Code arrhythmia (I44.x–I49.x) separately; may represent late post-repair complication |
Do not assign Q21.9 (Congenital malformation of cardiac septum, unspecified) or Q24.9 (Congenital malformation of heart, unspecified) when a more specific defect is documented or can be confirmed via query. Current ICD-10-CM includes specific ASD subcategories (Q21.10–Q21.19) — query for the specific ASD type when clinically supported. Similarly, AVSD has partial (Q21.21), transitional (Q21.22), and complete (Q21.23) subcategories in the current ICD-10-CM tabular.
🦴 Anatomy & Pathophysiology
Normal cardiac development: The heart develops from the cardiac crescent during weeks 3–8 of gestation. Key developmental processes include cardiac looping, septation (formation of atrial and ventricular septa), and outflow tract development. Disruption during these critical windows leads to the spectrum of CHD, as detailed by the NIH StatPearls developmental cardiology reference.
Hemodynamic consequences by defect type:
- Left-to-right shunts (VSD, ASD, AVSD, PDA): Oxygenated blood recirculates through the pulmonary vasculature → pulmonary overcirculation → right heart volume overload → pulmonary hypertension if untreated → eventual Eisenmenger syndrome (R→L shunt reversal). VSD produces Qp:Qs ratio >1.5:1 when hemodynamically significant.
- Right-to-left shunts (TOF, TGA, pulmonary atresia, HLHS): Deoxygenated blood enters systemic circulation → central cyanosis → systemic arterial oxygen desaturation. In TOF, infundibular spasm precipitates hypercyanotic “tet spells.”
- Obstructive lesions (coarctation of aorta, aortic stenosis, pulmonary stenosis): Fixed outflow obstruction → pressure overload → ventricular hypertrophy → heart failure if severe or untreated.
- HLHS (Q23.4): Underdevelopment of left-sided structures (aortic valve, mitral valve, left ventricle, ascending aorta) → single-ventricle circulation → systemic output depends on ductal patency; ductal closure at birth is fatal without immediate intervention.
- TGA (Q20.3): Aorta arises from RV, pulmonary artery from LV → two parallel, non-mixing circulations → incompatible with life unless communication exists (ASD, VSD, PDA).
- TAPVC (Q26.2): All four pulmonary veins drain anomalously (to right atrium, coronary sinus, or systemic veins) → obligate R→L shunt through ASD; obstructed TAPVC is a neonatal emergency.
Genetic associations: Approximately 20–30% of CHD cases have an identifiable genetic cause. Key associations include: Trisomy 21 / Down syndrome (Q90.x) → AVSD (40%), ASD, VSD; 22q11.2 deletion/velocardiofacial syndrome (Q93.81) or Di George’s syndrome (D82.1) → conotruncal defects (TOF, truncus arteriosus, interrupted aortic arch); Marfan syndrome (Q87.410) → aortic dilation/dissection risk; Turner syndrome (Q96.x) → bicuspid aortic valve, coarctation of aorta; Noonan syndrome (Q87.19) → pulmonary stenosis, HCM, per American Heart Association guidelines.
💊 Medication Impact / Treatment
Pharmacologic management is used as primary or adjunctive therapy for CHD, and medications documented in the record may serve as clinical indicators for specific conditions. Coders should review the medication reconciliation list as a CDI trigger.
Prostaglandin E1 (alprostadil, PGE1): Maintains ductal patency in duct-dependent lesions (HLHS, TGA, coarctation, pulmonary atresia) prior to surgical intervention. Presence of PGE1 infusion in a neonate strongly indicates critical CHD requiring immediate coding attention.
Diuretics (furosemide, spironolactone, chlorothiazide): Used for congestive heart failure management in CHD with significant L→R shunt (VSD, AVSD, PDA). Document associated heart failure (I50.x) with the underlying CHD code.
ACE inhibitors / ARBs (captopril, enalapril, losartan): Reduce afterload in CHD with ventricular dysfunction or heart failure; used in Marfan syndrome to slow aortic dilation.
Digoxin: Cardiac glycoside used for rate control and inotropic support in CHD-associated heart failure or arrhythmia management.
Beta-blockers (propranolol, atenolol): Propranolol is classic treatment for hypercyanotic tet spells in TOF; also used for arrhythmia management post-repair and in Marfan syndrome.
Endothelin receptor antagonists / PDE5 inhibitors (bosentan, sildenafil): Used for pulmonary arterial hypertension associated with CHD (secondary PAH, I27.21; Eisenmenger syndrome, I27.83). Presence of these medications should trigger query for associated PAH coding.
Indomethacin / Ibuprofen (IV): COX inhibitors used pharmacologically to close PDA in premature neonates. Successful closure results in resolved PDA → code PDA while active; use Z87.74 after confirmed closure in subsequent encounters.
Anticoagulants (warfarin, heparin, DOACs): Used in CHD patients with mechanical valve prostheses, atrial arrhythmias, Fontan palliation, or hypercoagulable states; code underlying indication.
When a patient on PDE5 inhibitors (sildenafil) or endothelin antagonists (bosentan) carries a CHD diagnosis, ensure pulmonary hypertension (I27.21 or I27.83) is documented and coded when supported by the provider’s diagnosis. These medications serve as a CDI trigger for secondary PAH coding and resource utilization documentation. Per ICD-10-CM tabular instructions, code I27.21 requires an additional code for the associated condition (Q20–Q28 when CHD is the cause), as referenced in the FY2027 ICD-10-CM Tabular.
Preview ends here. The full guide continues with FY2027 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
📘 ICD-10-CM Guidelines
The following guidelines govern assignment of Q20–Q28 codes for FY2027 (effective October 1, 2026), as published in the ICD-10-CM Official Guidelines for Coding and Reporting, FY2027.
Chapter 17 General Guidelines — Congenital Malformations, Deformations, Chromosomal Abnormalities, and Genetic Disorders (Q00–QA1)
- Lifelong coding: Codes from Q00–Q99 may be used throughout the life of the patient if the condition is still clinically present (Chapter 17, Section I.C.17). Unlike perinatal codes, Q-codes have no age restriction.
- Sequencing: The congenital defect is the principal diagnosis when the encounter is primarily for the defect itself or its repair. When the encounter is for management of a manifestation (e.g., heart failure, arrhythmia), sequence the manifestation as principal and the underlying CHD as additional diagnosis.
- Corrected conditions: When a congenital malformation has been corrected and is no longer clinically relevant, assign Z87.74 (Personal history of [corrected] congenital malformations of heart and circulatory system) — not the Q-code. Query providers when documentation uses “history of” ambiguously.
- Multiple defects: Code each congenital malformation separately. Combination codes exist for specific syndromes (e.g., TOF at Q21.3 captures all four components); do not code components of a coded combination separately.
- POA (Present on Admission): Chapter 17 congenital malformation, deformation, chromosomal abnormality, and genetic disorder codes in the Q00–QA1 range should be checked against the current CMS POA exempt list for inpatient reporting; congenital anomaly codes are commonly POA-exempt, but always verify the specific code for FY2027.
Specific FY2027 Coding Notes for Q20–Q28
- ASD expanded subcodes (Q21.1x): Current ICD-10-CM provides granular ASD subcategories. Q21.10 = unspecified ASD; Q21.11 = secundum ASD; Q21.12 = patent foramen ovale (PFO); Q21.13 = coronary sinus ASD; Q21.14 = superior sinus venosus ASD; Q21.15 = inferior sinus venosus ASD; Q21.16 = sinus venosus ASD, unspecified; Q21.19 = other specified ASD. Document and query for specificity.
- AVSD expanded subcodes (Q21.2x): Current ICD-10-CM provides Q21.20 = unspecified AVSD; Q21.21 = partial AVSD; Q21.22 = transitional AVSD; Q21.23 = complete AVSD. The distinction between partial, transitional, and complete AVSD is clinically and surgically significant and should be confirmed via query when not documented.
- Bicuspid aortic valve (Q23.81): Use the current specific code Q23.81 when bicuspid aortic valve is documented without congenital aortic valve stenosis or insufficiency as the sole finding. If congenital stenosis or insufficiency is documented, code the specific valve condition as supported by the record.
- Pulmonary hypertension and CHD: When secondary pulmonary arterial hypertension (I27.21) is caused by congenital heart disease, code I27.21 first, then add the CHD code (Q20–Q28). If Eisenmenger syndrome develops, assign I27.83 + the underlying structural defect Q-code.
- Tetralogy of Fallot (Q21.3): This is a combination code encompassing all four components (VSD, pulmonary stenosis/atresia, overriding aorta, RVH). Do not code the inherent components separately. Assign Q21.3 when the condition is documented and clinically active; if the malformation has been corrected and is no longer clinically relevant, use the appropriate personal history code instead.
- Associated genetic syndromes: When CHD is associated with Down syndrome (Q90.x), Di George’s syndrome (D82.1), documented 22q11.2 deletion/velocardiofacial syndrome (Q93.81), Marfan syndrome (Q87.410), Turner syndrome (Q96.x), or another genetic syndrome, code both the syndrome/genetic condition and the specific cardiac defect.
- HLHS palliation status: After Norwood stage 1, code Q23.4 (HLHS) for the underlying condition and appropriate Z-codes for device/anastomosis status when applicable. Fontan-related circulation and documented Fontan-associated conditions are captured with I27.84- codes; use Z95.x only for applicable cardiac or vascular implant/graft status.
Auditors frequently identify under-coding of ASD and AVSD specificity post-FY2026. The unspecified codes Q21.10 and Q21.20 are valid only when the specific ASD or AVSD type is truly not documented. Review echocardiogram reports, catheterization reports, and operative notes—these routinely specify secundum vs. sinus venosus ASD, and partial vs. complete AVSD—before defaulting to an unspecified code. Query the cardiologist or cardiac surgeon if type remains unclear.
🔢 ICD-10-CM Code Set (Tabular)
The following table presents the primary FY2027 ICD-10-CM codes for congenital circulatory malformations, verified against the CMS FY2027 ICD-10-CM tabular list and the Q20–Q28 code range. MS-DRG assignments reference MS-DRG v44.0 (CMS).
| ICD-10-CM Code | Description | MS-DRG (v43) | Coding Notes |
|---|---|---|---|
| Q20.0 | Common arterial trunk (truncus arteriosus) | DRG 306/307 | Critical CHD; requires immediate neonatal intervention |
| Q20.1 | Double outlet right ventricle (DORV) | DRG 306/307 | Varied subtypes; may resemble TOF or TGA hemodynamically |
| Q20.3 | Discordant ventriculoarterial connection (TGA) | DRG 306/307 | D-TGA; critical CHD; requires arterial switch operation |
| Q20.4 | Double inlet ventricle (single ventricle) | DRG 306/307 | Single ventricle physiology; Fontan palliation pathway |
| Q21.0 | Ventricular septal defect | DRG 306/307 | Most common CHD; small muscular may close spontaneously |
| Q21.10 | Atrial septal defect, unspecified | DRG 306/307 | FY2026: use only when type not documented; query for specificity |
| Q21.11 | Secundum atrial septal defect | DRG 306/307 | Most common ASD type; mid-fossa; device closure or surgery |
| Q21.12 | Patent foramen ovale | DRG 306/307 | FY2026 specific code; risk of paradoxical embolism/stroke |
| Q21.13 | Coronary sinus atrial septal defect | DRG 306/307 | Rare; associated with persistent left SVC |
| Q21.14 | Superior sinus venosus atrial septal defect | DRG 306/307 | Associated with anomalous pulmonary venous return |
| Q21.15 | Inferior sinus venosus atrial septal defect | DRG 306/307 | FY2026 new subcode; near inferior vena cava |
| Q21.19 | Other specified atrial septal defect | DRG 306/307 | Use when ASD documented but does not fit other categories |
| Q21.20 | Atrioventricular septal defect, unspecified | DRG 306/307 | Use only when partial vs. complete not documented |
| Q21.21 | Partial AVSD (ostium primum ASD) | DRG 306/307 | FY2026 subcode; incomplete endocardial cushion defect |
| Q21.22 | Transitional AVSD | DRG 306/307 | FY2026 subcode; intermediate form |
| Q21.23 | Complete AVSD | DRG 306/307 | FY2026 subcode; common in Down syndrome; single AV valve |
| Q21.3 | Tetralogy of Fallot | DRG 306/307 | Combination code; do NOT code 4 components separately |
| Q22.0 | Pulmonary valve atresia | DRG 306/307 | Critical CHD; associated with VSD in many cases |
| Q22.1 | Congenital pulmonary valve stenosis | DRG 306/307 | Common; balloon valvuloplasty or surgery |
| Q22.4 | Congenital tricuspid stenosis | DRG 306/307 | Tricuspid atresia included here; hypoplastic RV |
| Q22.5 | Ebstein’s anomaly | DRG 306/307 | Tricuspid valve displacement; ASD almost always present |
| Q22.6 | Hypoplastic right heart syndrome | DRG 306/307 | Single ventricle palliation; Fontan pathway |
| Q23.0 | Congenital stenosis of aortic valve | DRG 306/307 | Critical if severe; neonatal balloon valvotomy or Ross procedure |
| Q23.1 | Congenital insufficiency of aortic valve | DRG 306/307 | Aortic regurgitation from congenital malformation |
| Q23.2 | Congenital mitral stenosis | DRG 306/307 | Parachute mitral valve; supramitral ring |
| Q23.4 | Hypoplastic left heart syndrome (HLHS) | DRG 306/307 (MCC) | Critical CHD; Norwood → Glenn → Fontan palliation; high resource use |
| Q23.81 | Bicuspid aortic valve | DRG 306/307 | Specific subcode; risk of stenosis, regurgitation, and aortopathy |
| Q24.0 | Dextrocardia | DRG 306/307 | Code with situs inversus (Q89.3) if applicable |
| Q24.5 | Malformation of coronary vessels | DRG 306/307 | Coronary artery anomalies; anomalous LMCA from PA (ALCAPA) |
| Q25.0 | Patent ductus arteriosus | DRG 306/307 | Common in preemies; prostaglandin-dependent lesions |
| Q25.1 | Coarctation of aorta | DRG 306/307 | Upper extremity HTN; differential pulse pressures; associated with BAV |
| Q25.21 | Interruption of aortic arch | DRG 306/307 | Atresia of aortic arch; critical CHD; associated with DiGeorge/22q11.2 deletion in some patients |
| Q25.29 | Other atresia of aorta | DRG 306/307 | Use for congenital atresia of aorta other than interruption/atresia of the aortic arch |
| Q25.3 | Supravalvular aortic stenosis | DRG 306/307 | Williams syndrome association (Q93.82) |
| Q25.5 | Atresia of pulmonary artery | DRG 306/307 | Critical CHD; systemic-to-pulmonary collaterals (MAPCAs) |
| Q25.6 | Stenosis of pulmonary artery | DRG 306/307 | Branch PA stenosis; may be peripheral |
| Q26.2 | Total anomalous pulmonary venous connection (TAPVC) | DRG 306/307 | Critical CHD; obstructed form is neonatal emergency |
| Q26.3 | Partial anomalous pulmonary venous connection (PAPVC) | DRG 306/307 | Partial return; often associated with sinus venosus ASD |
| I27.21 | Secondary pulmonary arterial hypertension | MDC 04/05 (varies) | “Code also” CHD (Q20–Q28) per tabular instruction; not in Q20–Q28 range but critical comorbidity |
| I27.83 | Eisenmenger syndrome | MDC 04/05 | Code also underlying structural defect (Q-code) |
| I27.840 | Fontan-associated liver disease [FALD] | MDC 05 | Use when FALD is documented in a patient with Fontan circulation |
| I27.841 | Fontan-associated lymphatic dysfunction | MDC 05 | Use when Fontan-associated lymphatic dysfunction is documented |
| I27.848 | Other Fontan-associated condition | MDC 05 | Use for other specified Fontan-associated condition |
| I27.849 | Fontan related circulation, unspecified | MDC 05 | Use when Fontan-related circulation is documented without a more specific I27.84- condition |
| Q90.x | Down syndrome (trisomy 21) | Various | Always code associated CHD separately (AVSD most common) |
| Q93.81 | Velo-cardio-facial syndrome / documented 22q11.2 deletion | Various | Use D82.1 when the provider documents Di George’s syndrome; code associated conotruncal defects (TOF, interrupted arch) separately |
| Z87.74 | Personal history of (corrected) congenital malformations of heart and circulatory system | N/A (supplemental) | Use ONLY when defect is fully corrected and no longer clinically relevant |
| Z95.x | Presence of cardiac and vascular implants and grafts | Various | Use for Fontan conduit, shunt, valve prosthesis status post-CHD repair |
🔎 Indexing
The ICD-10-CM Alphabetic Index provides multiple entry points for congenital circulatory malformations. Key index terms and their code pathways:
- Defect → Heart → congenital → septal → ventricular (Q21.0); atrial → secundum (Q21.11)
- Tetralogy of Fallot → Q21.3
- Transposition → great arteries (vessels) → Q20.3; complete → Q20.3
- Hypoplastic → left heart (syndrome) → Q23.4
- Patent → ductus arteriosus → Q25.0
- Coarctation → aorta (preductal) (postductal) → Q25.1 Atresia → aorta → Q25.29; arch → Q25.21
- Anomaly → pulmonary venous connection (total) (partial) → Q26.2 / Q26.3
- Ebstein’s anomaly → Q22.5
- Truncus arteriosus → Q20.0
- Syndrome → DiGeorge → Q93.81; Down → Q90.x; Eisenmenger → I27.83
- Valve → aortic → congenital → bicuspid → Q23.81; stenosis → Q23.0
- History of (personal) → malformation → heart (corrected) → Z87.74
For Norwood, Fontan, and Glenn procedures, the Alphabetic Index routes through the procedure (CPT/ICD-10-PCS) rather than the diagnosis. The underlying CHD diagnosis should be coded from the Q-code range based on clinical documentation. The index entry Procedure → Palliation → cardiac → single ventricle leads to CPT codes, not diagnosis codes. Always code the underlying defect (e.g., Q23.4 for HLHS, Q20.4 for single ventricle) separately.
🏥 CPT
CPT codes for CHD surgical and catheter-based intervention are complex and high-value. The following table presents key 2027 CPT codes, verified against the 2027 CPT update files and current congenital cardiac catheterization guidance.
| CPT Code | Description | Global Days | Key Notes |
|---|---|---|---|
| 33600 | Valvotomy, pulmonary valve; open heart, with cardiopulmonary bypass | 90 | Congenital pulmonary stenosis; repair Q22.1 |
| 33602 | Valvotomy, pulmonary valve; closed heart | 90 | Closed approach; code with appropriate CHD dx |
| 33608 | Repair of complex cardiac anomaly (other than PA with VSD) by construction of conduit from RV to pulmonary artery | 90 | RV-PA conduit; used in truncus arteriosus, pulmonary atresia |
| 33610 | Repair of complex cardiac anomaly by application of patch enlargement of right ventricular outflow tract | 90 | RVOT patch; TOF repair component |
| 33611 | Repair of double outlet right ventricle with intraventricular tunnel repair | 90 | DORV with subaortic VSD (Rastelli-type); Q20.1 |
| 33615 | Repair of complex cardiac anomalies (e.g., tricuspid atresia) by closure of ASD and anastomosis of atria or vena cava to pulmonary artery (simple Fontan) | 90 | Fontan stage; Q22.4 or Q20.4 primary diagnosis |
| 33619 | Repair of single ventricle with aortic outflow obstruction and aortic arch hypoplasia (HLHS) — Norwood stage 1 | 90 | Highest complexity; Q23.4 (HLHS) primary; extremely high resource DRG |
| 33622 | Reconstruction of complex cardiac anomaly (single ventricle or HLHS) — Stage 2 Norwood/bidirectional Glenn | 90 | Hybrid or stage 2 palliation; Q23.4 or Q20.4 dx |
| 33641 | Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch | 90 | Open ASD repair; Q21.11; device closure coded differently |
| 33645 | Direct or patch closure, sinus venosus, with or without anomalous pulmonary venous drainage | 90 | Sinus venosus ASD repair; Q21.14 or Q21.15 |
| 33647 | Repair of atrial septal defect and ventricular septal defect, with direct or patch closure | 90 | Combined ASD + VSD repair; code both Q21.11 + Q21.0 |
| 33660 | Repair of incomplete or partial atrioventricular canal (ostium primum ASD), with or without mitral valve repair | 90 | Partial AVSD repair; Q21.21 |
| 33665 | Repair of incomplete or partial atrioventricular canal with ventricular septal defect | 90 | Partial AVSD + VSD |
| 33670 | Repair of complete atrioventricular canal, with or without prosthetic valve | 90 | Complete AVSD repair; Q21.23; common in Down syndrome |
| 33681 | Closure of single ventricular septal defect, with or without patch | 90 | VSD closure; Q21.0; most common open heart procedure in CHD |
| 33684 | Closure of single VSD with pulmonary valvotomy or infundibular resection | 90 | VSD + RVOT obstruction; component of TOF repair |
| 33694 | Complete repair tetralogy of Fallot without pulmonary atresia, with transannular patch | 90 | TOF repair with TAP; Q21.3; transannular patch increases PR risk |
| 33730 | Complete repair of anomalous pulmonary venous return (supracardiac, infracardiac, or mixed) | 90 | TAPVC repair; Q26.2; obstructed form highest risk |
| 33755 | Pulmonary artery banding | 90 | Palliative; used for large VSD, complete AVSD prior to repair |
| 33762 | Aortic arch repair (coarctation) via patch | 90 | Coarctation repair; Q25.1 |
| 33764 | Aortic arch repair; coarctation with bypass graft | 90 | Extended resection CoA with bypass; Q25.1 |
| 33770 | Repair of transposition of the great arteries with ventricular septal defect and subpulmonary obstruction (Rastelli operation) | 90 | Rastelli for TGA + VSD + PS; Q20.3 + Q21.0 + Q22.1 |
| 33774 | Repair of transposition of great arteries, atrial level procedure (Mustard or Senning) | 90 | Atrial switch; historical but still coded for revisions |
| 33782 | Aortic root translocation with VSD and pulmonary stenosis repair (Nikaidoh procedure), without coronary ostium reimplantation | 90 | Not the standard Jatene arterial switch; use for TGA/VSD/PS anatomy when Nikaidoh procedure is documented |
| 33924 | Ligation and takedown of systemic-to-pulmonary artery shunt, with or without CPB | 90 | Takedown of Blalock-Taussig or other palliative shunt |
| 33860 | Ascending aorta graft with CPB, with aortic valve suspension (Yacoub/Cabrol) | 90 | Aortic root/arch anomaly; Marfan (Q87.410) or Q25.4x |
Do not confuse 33641 (open surgical ASD repair with CPB) with percutaneous/transcatheter ASD closure. Transcatheter device closure is reported with CPT codes from the structural heart intervention range (93580, 93581 for PFO/ASD closure with implant). When a closure device (e.g., Amplatzer occluder) is used, the appropriate structural heart CPT code applies—not 33641. Review the operative/procedural report carefully to determine whether the approach was open (33641) or percutaneous (93580/93581). 2027 CPT update: Codes 33745 and +33746 for transcatheter intracardiac shunt (TIS) procedures were revised for congenital cardiac anomalies. The 33745 descriptor now refers to stent placement in the initial shunt site to establish intracardiac blood flow using imaging guidance; +33746 now describes creation/enlargement at each additional intracardiac shunt location and adds pulmonary vein to the target-zone examples.
- 33745: 2026 descriptor referred to TIS creation by placement of stent in the initial shunt site for congenital cardiac anomaly to create effective intracardiac flow, using imaging guidance and target zone angioplasty; revised for 2027 to stent placement in the initial shunt site for congenital cardiac anomalies to establish intracardiac blood flow using imaging guidance.
- 33746: 2026 descriptor referred to creation of an additional intracardiac shunt location; revised for 2027 to creation/enlargement at each additional intracardiac shunt location and adds pulmonary vein to the target-zone examples.
🧾 HCPCS
The following HCPCS Level II codes are relevant for supplies, devices, and services used in the management of congenital circulatory malformations, per CMS HCPCS 2026.
| HCPCS Code | Description | Typical Use in CHD |
|---|---|---|
| C1749 | Endovascular prosthesis (branched/fenestrated; aortic) | Endovascular aortic repair; aortic coarctation stent-graft (Q25.1) |
| C1752 | Catheter, balloon dilatation, non-vascular | Balloon valvuloplasty (pulmonary, aortic valves); catheter-based CHD intervention |
| C1762 | Connective tissue, human (includes fascia lata) | Patch material for septal defect repair (VSD, ASD) |
| C1781 | Mesh (implantable) | Pericardial or synthetic patch for VSD/ASD/AVSD repair |
| C1830 | Powered bone marrow biopsy needle | Not typically used in CHD; confirm applicability |
| C2625 | Stent, non-coronary, temporary, without delivery system | Pulmonary artery stent (branch PA stenosis, Q25.6) |
| C1756 | Needle, access, flood (all types) | Procedural supply, cardiac catheterization lab |
| L8670 | Auditory osseointegrated device, includes all internal and external components | Not CHD-specific; verify indication |
| C1882 | Cardioverter-defibrillator, other than single or dual chamber | Subcutaneous ICD placement for post-repair arrhythmia in CHD patients |
| C1900 | Lead, left ventricular coronary venous system (for CRT) | CRT-D lead in CHD patients with ventricular dyssynchrony |
| S2400 | Repair, congenital cardiac anomaly (procedure not elsewhere classified) | Non-Medicare payers; used for complex CHD repairs not covered by specific CPT codes |
📚 AHA Coding Clinic
The following AHA Coding Clinic items were confirmed against the Coding Clinic articles linked to each code (Find-A-Code, November 2026). Where Coding Clinic has not addressed a topic, the ICD-10-CM Tabular instruction that controls is noted instead.
- Coding Clinic, First Quarter 2026 and Fourth Quarter 2026 — Official Guidelines, Chapter 17: Both issues reprint the guideline: “Codes from Chapter 17 may be used throughout the life of the patient. If a congenital malformation or deformity has been corrected, a personal history code should be used to identify the history of the malformation or deformity.” The Z87.7 Excludes2 note keeps the Q code for malformations “partially corrected or repaired but which still require medical treatment.” (1Q 2026; 4Q 2026)
- Coding Clinic, Fourth Quarter 2022 — New ASD, AVSD, and PFO codes: Introduced subcategories Q21.1- (atrial septal defect, including Q21.12 patent foramen ovale) and Q21.2- (atrioventricular septal defect: Q21.20 unspecified, Q21.21 partial, Q21.22 transitional, Q21.23 complete). Code to the documented type; query when the echo or operative report does not state it. (4Q 2022)
- Coding Clinic, Third Quarter 2014 — Repair of tetralogy of Fallot: Assign Q21.3 for tetralogy; components of the anomaly, such as right ventricular outflow obstruction, are not coded separately. The article does not address regurgitation after repair; for post-repair pulmonary regurgitation, follow the Index (Regurgitation, pulmonary → I37.1; congenital → Q22.2) and query when the cause is not documented. (3Q 2014)
- Eisenmenger syndrome (Tabular instruction): FY 2027 ICD-10-CM I27.83 carries a “code also” note for the underlying heart defect, if known (for example, Q21.1-, Q21.0, Q25.0). No Coding Clinic article specific to this pairing was found.
- Status-post repair with residual or ongoing disease: No Coding Clinic article specific to “history of” VSD or other CHD repair was found. Apply Guideline I.C.17 and the Z87.7 Excludes2 note above: residual lesions or ongoing treatment keep the Q code; fully corrected with no ongoing treatment uses Z87.74.
When a patient with a history of CHD repair presents with cardiac symptoms (dyspnea, arrhythmia, syncope, reduced exercise tolerance), query the attending/cardiologist: “Is the patient’s [specific CHD] considered fully corrected (no longer clinically relevant) or is it still considered present and clinically active? If still active, are there any residual effects (e.g., pulmonary valve regurgitation post-TOF repair, RV dysfunction, residual shunt) that should be documented as diagnoses?” Clear status documentation supports accurate diagnosis, severity, and risk capture. Keep the query itself free of any reference to payment or quality scores.
💰 HCC / Risk Adjustment
Under the CMS-HCC Model Version 28, use the current payment-year CMS model software/ICD-10 mappings to determine whether a documented CHD or associated condition maps for Medicare Advantage risk adjustment. Do not assume a blanket CMS-HCC assignment for Q20–Q26 congenital heart codes; CHD, pulmonary hypertension, Fontan-related conditions, heart failure, arrhythmias, and genetic/immunologic syndromes must be checked code-by-code and model-year-by-model-year.
| ICD-10-CM Code(s) | HCC v28 Category | HCC v28 RAF Weight (Approx.) | Risk Adjustment Impact |
|---|---|---|---|
| Q20.x–Q26.x (congenital heart/circulatory defects) | No blanket CMS-HCC V28 category; verify each ICD-10-CM code in the current CMS payment-year mapping | Varies by model and code; many CHD codes may affect MS-DRG severity or RxHCC rather than CMS-HCC | Do not use HCC 162 as a congenital heart disease category in CMS-HCC V28 |
| Q23.4 (HLHS), Q20.3 (TGA), Q20.0 (truncus arteriosus) | Verify each code in the current CMS-HCC mapping; do not assign HCC 162 as a critical CHD subset | Varies by model and member context | These diagnoses remain clinically high complexity and may affect MS-DRG severity and care management even when they do not map to a CMS-HCC payment category |
| I27.21 (Secondary pulmonary arterial hypertension) | CMS-HCC V28 HCC 226 (Heart Failure, Except End Stage and Acute), when accepted by the applicable payment-year mapping | Weight varies by payment year and member segment | Significant CHD-related vascular complication; code also the associated condition, such as CHD (Q20–Q28), when documented |
| I27.83 (Eisenmenger syndrome) | CMS-HCC V28 HCC 226 (Heart Failure, Except End Stage and Acute), when accepted by the applicable payment-year mapping; code also the underlying structural defect | Weight varies by payment year and member segment | High-complexity CHD pulmonary complication; do not add HCC 162 as a CHD category under CMS-HCC V28 |
| I50.x (Heart failure with CHD) | CMS-HCC V28 HCC 224, 225, or 226 depending on acuity/type and hierarchy | Weight varies by payment year and member segment | Document specific HF type and acuity; do not assume additive RAF from the CHD code unless the CHD code itself maps in the applicable model |
| Q90.x (Down syndrome with CHD) | Verify current CMS-HCC mapping; do not assume HCC 155 as a chromosomal-abnormality category in CMS-HCC V28 | Varies by model and member context | Code Down syndrome and the specific cardiac defect when documented; capture associated intellectual disability or other conditions separately when supported |
| D82.1 (Di George’s syndrome) or Q93.81 (velocardiofacial syndrome / documented 22q11.2 deletion) | Verify the documented term and current CMS-HCC mapping; Q93.81 is not the code descriptor for Di George’s syndrome | Weight varies by code, model year, and member context | Code the associated CHD separately; do not assume a combined RAF impact without current CMS mapping validation |
| I44.x–I49.x (Arrhythmias post-CHD repair) | CMS-HCC V28 HCC 238 for selected specified heart arrhythmias, when accepted by the applicable payment-year mapping | Weight varies by payment year and member segment | Post-repair arrhythmias may carry RAF when the specific documented arrhythmia maps; document arrhythmia type separately |
| Z95.x (Presence of cardiac implant/graft) | Supplemental (no direct RAF) | N/A | Documents device status; important for care management and audit defense; no direct HCC |
| Z87.74 (History of corrected CHD) | No HCC assignment | 0 | No RAF impact; use only when condition is fully resolved — do not use when CHD is still active |
Key v28 HCC principles for CHD: CMS-HCC risk adjustment depends on the current CMS payment-year ICD-10-CM mappings, accepted diagnoses, hierarchy logic, and member segment. Providers should document annually whether CHD is still present and clinically relevant, along with specific associated comorbidities such as pulmonary hypertension, heart failure, Fontan-associated conditions, arrhythmias, immunodeficiency/genetic syndromes, and device status when applicable. Adults with CHD, particularly those who have undergone surgical palliation, carry significant resource utilization burdens that should be fully captured through accurate diagnosis coding and current-year mapping validation.
For Medicare Advantage adult patients with a history of CHD, query the provider at each annual wellness visit or cardiology encounter: “Is [specific congenital defect] still present and clinically active? What is the current functional status? Are there any associated conditions (pulmonary hypertension, arrhythmia, heart failure, residual shunt) that should be documented?” Annual documentation of active CHD and comorbidities is required for RAF recapture in subsequent plan years. Failure to document annually results in RAF credits expiring even when the condition persists.
✍️ CDI Query Templates
All queries below comply with AHIMA and ACDIS compliant query standards: non-leading, multiple choice, clinically supported, and purpose-stated.
| Clinical Scenario | Query Wording (Non-Leading, Multiple Choice) |
|---|---|
| ASD documented without type specification (e.g., “ASD” only, echo report available) | “The echo report describes an atrial septal defect. For accurate coding and documentation, could you clarify the type of ASD? Options: (A) Secundum ASD; (B) Patent foramen ovale (PFO); (C) Sinus venosus ASD (superior); (D) Sinus venosus ASD (inferior); (E) Coronary sinus ASD; (F) Ostium primum ASD; (G) Other/not specified. Clinical basis: [echo report findings].” |
| AVSD repair documented without partial vs. complete specification | “The operative note documents repair of an atrioventricular septal defect (AV canal). For coding accuracy, could you clarify the type? Options: (A) Partial AVSD (ostium primum ASD with cleft mitral valve, no VSD); (B) Transitional AVSD (primum ASD + small inlet VSD); (C) Complete AVSD (common AV valve, primum ASD + inlet VSD); (D) Other/unable to specify. Basis: operative report documentation.” |
| “History of” VSD repair with ongoing cardiac symptoms | “The record notes a history of VSD repair. Based on current clinical presentation (e.g., murmur, cardiac imaging, symptoms), which of the following best characterizes the current status? Options: (A) VSD fully corrected — no longer clinically present or relevant; (B) VSD still present — residual defect with or without hemodynamic significance; (C) VSD repaired but with residual effects (specify: e.g., pulmonary hypertension, ventricular dysfunction, arrhythmia); (D) Unable to determine without further testing.” |
| Pulmonary hypertension in a patient with known CHD | “The record documents pulmonary hypertension in the context of congenital heart disease. Could you clarify the pulmonary hypertension classification? Options: (A) Secondary pulmonary arterial hypertension (Group 1; PAH due to CHD shunting); (B) Pulmonary hypertension due to left heart disease (Group 2); (C) Eisenmenger syndrome (irreversible PAH with reversed shunt); (D) Pulmonary hypertension due to hypoxia/lung disease (Group 3); (E) Other/unspecified. Basis: echocardiography and/or catheterization findings.” |
| Post-TOF repair patient with new arrhythmia | “The patient has repaired tetralogy of Fallot and the record documents arrhythmia. Could you clarify: (A) Is the TOF considered fully corrected (no clinically relevant residual) or still present with active residual effects? (B) If present, what residual effects exist (e.g., pulmonary regurgitation, RV dilation/dysfunction, residual RVOT obstruction)? (C) What is the arrhythmia type (e.g., complete heart block, ventricular tachycardia, atrial flutter/fibrillation, other)? This clarification will ensure all active diagnoses are accurately documented.” |
| Down syndrome patient admitted with cardiac decompensation | “The patient has Down syndrome (trisomy 21) and was admitted for cardiac symptoms. Could you clarify: (A) Is there a known congenital cardiac defect (e.g., AVSD, VSD, ASD) — if so, please specify; (B) Is this defect currently repaired, unrepaired, or partially repaired? (C) Is the current cardiac decompensation related to the structural defect, heart failure, arrhythmia, or other cause? (D) Is pulmonary hypertension present as a contributing condition?” |
🧑⚕️ Treatments (Clinical)
Treatment for congenital circulatory malformations depends on defect type, severity, associated lesions, and patient age/condition. Documentation of treatment approach informs coding, DRG assignment, and clinical validation.
Interventional (Catheter-Based)
- Transcatheter ASD/VSD closure: Percutaneous device closure (e.g., Amplatzer Septal Occluder) for secundum ASD and selected VSDs. Less invasive than open surgery; increasingly first-line for amenable defects. CPT 93580 (transcatheter ASD closure), 93581 (VSD closure).
- Balloon valvuloplasty: For congenital pulmonary stenosis (Q22.1) or aortic stenosis (Q23.0); dilates stenotic valve via balloon catheter. CPT 92990 (pulmonary), 92986 (aortic).
- Transcatheter pulmonary valve replacement (TPVI): Melody or Sapien XT valve delivered via catheter into RV outflow tract conduit in post-TOF repair or pulmonary stenosis patients. CPT 33477.
- Coarctation stenting: Endovascular stent placement in adolescents/adults with CoA; balloon angioplasty in neonates (Q25.1).
- Transcatheter atrial septostomy (Rashkind/Sang-Park/balloon/cutting balloon/blade): Emergency palliation for TGA, HLHS, or other congenital cardiac anomalies to create/enlarge atrial-level mixing. CPT 33741 reports transcatheter atrial septostomy by any method; CPT 92992 and 92993 were deleted and should not be used for current dates of service.
Surgical (Open Heart)
- Norwood procedure (Stage 1): Neonatal palliation for HLHS (Q23.4). Reconstructs neo-aorta from main pulmonary artery + ascending aorta; creates systemic-to-pulmonary shunt (Blalock-Taussig-Thomas shunt or Sano shunt). CPT 33619.
- Bidirectional Glenn / Stage 2: Superior cavopulmonary anastomosis (SVC to pulmonary artery). CPT 33766, 33767, or component of 33622.
- Fontan completion (Stage 3): Total cavopulmonary connection (TCPC); inferior vena cava to pulmonary artery via extracardiac conduit or lateral tunnel. CPT 33615.
- Arterial switch operation (Jatene): Definitive repair of TGA (Q20.3); aorta and pulmonary artery transected and switched to appropriate ventricles; coronary reimplantation required. Report the appropriate arterial switch code from the transposition repair family based on documentation of associated band removal, VSD closure, or subpulmonic obstruction; do not use 33782 for a standard Jatene arterial switch because 33782 describes the Nikaidoh/aortic root translocation procedure.
- TOF complete repair: VSD patch closure + RVOT reconstruction (resection of infundibular stenosis ± transannular patch). CPT 33692, 33694. Definitive repair typically performed at 3–6 months of age.
- TAPVC repair: Anastomosis of anomalous pulmonary venous confluence to left atrium; closure of ASD. CPT 33730. Obstructed form requires emergent neonatal surgery.
- Coarctation repair: Resection and end-to-end anastomosis, patch aortoplasty, or subclavian flap repair. CPT 33840, 33845, 33851, 33852. Endovascular stenting for adolescents/adults.
Post-Repair Surveillance and Long-Term Management
Adults with congenital heart disease (ACHD) require lifelong subspecialty follow-up. The AHA/ACC 2018 ACHD Guidelines recommend dedicated ACHD center follow-up for complex lesions. Long-term issues include pulmonary valve dysfunction (post-TOF), Fontan circuit complications (protein-losing enteropathy, atrial arrhythmia, Fontan failure), aortopathy (BAV, Marfan, CoA), endocarditis prophylaxis (high-risk unrepaired or residual defects), and arrhythmia surveillance (24-hour Holter, ICD placement in selected patients).
🎓 Patient Education / Summary
What is congenital heart disease? Congenital heart disease (CHD) means the heart or the blood vessels near the heart did not form normally before birth. The word “congenital” means present at birth. CHD is the most common type of birth defect in the United States, affecting about 1 in 100 babies born each year, according to the CDC.
Types of heart defects: There are many types of CHD. Some, like a small hole in the wall between the heart’s chambers (ventricular septal defect or atrial septal defect), are mild and may close on their own. Others, such as tetralogy of Fallot, hypoplastic left heart syndrome, or transposition of the great arteries, are more complex and require surgery or other procedures, often shortly after birth.
Symptoms to know: CHD may cause bluish skin or lips (cyanosis), fast breathing, poor feeding, weight gain problems in infants, fatigue, or fainting during exercise. Some forms of CHD cause no symptoms at all and may only be discovered by a doctor’s examination or tests.
How is CHD treated? Many CHD conditions are treated with surgery, catheter procedures (minimally invasive), or medicines to manage symptoms. Some patients need multiple surgeries over their lifetime. Advances in medical care mean that most children born with CHD now live into adulthood.
Lifelong care is important: Even after treatment, people with CHD need regular follow-up with a heart specialist (cardiologist), preferably one specializing in adult congenital heart disease (ACHD). Regular check-ups help catch any problems early, manage medications, and monitor heart function over time. The American Heart Association recommends lifelong care for anyone born with a significant heart defect.
Genetic testing: Some CHDs run in families or are linked to chromosomal conditions like Down syndrome or DiGeorge syndrome. Genetic counseling may be recommended for patients with CHD or family members of affected individuals.
Why accurate diagnosis documentation matters: Complete and specific documentation of your CHD diagnosis helps your care team coordinate treatment, ensures insurance coverage for necessary services, supports long-term care planning, and helps track your health over time. If you have a repaired or managed heart defect, it is important that your doctors document its ongoing status each year to ensure your health record accurately reflects your heart condition.
About this Guide
This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026) and CPT 2027 (effective January 1, 2027, with CPT 2026 transition notes where applicable). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, AMA CPT guidance, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.
Last reviewed: October 2026 · Next scheduled review: November 2026 (CPT 2027 final check)
Ready to turn this knowledge into a credential?
These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.
CCO Hero
Know someone starting a medical coding career?
Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.
Become a CCO Hero